- Edwards SAPIEN 3 Valve Shows Excellent Results At 2 Years
- Edwards Pauses Enrollments In Pivotal Mitral, Tricuspid Trials In Response To Hospitals' Focus On COVID-19
- Edwards Lifesciences To Present At The Cowen 40th Annual Healthcare Conference
- Edwards Lifesciences' Every Heartbeat Matters Philanthropic Initiative Expanding To Reach More Patients
- Edwards Lifesciences Reports Fourth Quarter Results
- Edwards Lifesciences To Host Earnings Conference Call On January 30, 2020
As of last trade
Edwards Lifesciences Corp (EW:NYQ) traded at 203.50, -17.82% below its 52-week high of 247.64, set on Nov 19, 2019.
154.52Mar 23 2020247.64Nov 19 2019
Markit short selling activity
|Market cap||40.52bn USD|
|EPS (TTM)||4.95 |
Data delayed at least 15 minutes, as of Apr 07 2020 15:58 BST.